Blog

Mieke Van Hemelrijck: Kicking off Day 1 of the EORTC

Mieke Van Hemelrijck/LinkedIn

Mar 27, 2025, 13:05

Mieke Van Hemelrijck: Kicking off Day 1 of the EORTC

Mieke Van Hemelrijck, Professor of Cancer Epidemiology at King’s College London, shared a post on LinkedIn:

“Kicking off Day 1 of the EORTC – European Organisation for Research and Treatment of Cancer Quality of Life Group meeting with a stunning sunrise!

Looking forward to insightful discussions and updates from all teams. Today, TOUR: Transforming cancer outcomes through Research will share progress on key projects, including:

Immune Checkpoint Inhibitors – Louis Fox
Common Data Models – Charlotte Moss
Recruitment with Patient Organisations – Saran Green
Bladder Cancer – Elke Rammant and Marieke van Leeuwen
Prostate Cancer – Renée Bultijnck and Piet Ost

With some studies wrapping up Phase 1 & 2, others kicking off or preparing for Phase 3 and ethical approvals, there’s plenty of exciting progress ahead.

Stay tuned for more updates!”

Mieke Van Hemelrijck: Kicking off Day 1 of the EORTC

bladder cancer cancer Charlotte Moss Elke Rammant EORTC European Organisation for Research and Treatment of Cancer fight against cancer Global fight against cancer Immune Checkpoint Inhibitors Louis Fox Marieke van Leeuwen Mieke Van Hemelrijck OncoDaily Oncology Piet Ost prostate cancer Quality of Life Group Renée Bultijnck Saran Green

Meet the New AACR Board of Directores for 2025-2028 Term

Do Artificial Sweeteners Cause Cancer? Myths and Facts

King Charles III Hospitalized Following Side Effects from Cancer Treatment

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

MARIPOSA trial results presented at ELCC25 - BREAKING from Paris